Production (Stage)
SBC Medical Group Holdings Incorporated
SBC
$4.55
$0.7118.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 197.94M | 205.42M | 223.34M | 217.54M | 205.44M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 197.94M | 205.42M | 223.34M | 217.54M | 205.44M |
| Cost of Revenue | 43.67M | 49.37M | 57.80M | 61.73M | 57.13M |
| Gross Profit | 154.26M | 156.05M | 165.55M | 155.80M | 148.31M |
| SG&A Expenses | 82.45M | 83.62M | 95.15M | 79.13M | 83.34M |
| Depreciation & Amortization | 461.40K | 968.70K | 968.70K | 968.70K | 968.70K |
| Other Operating Expenses | 340.60K | 195.20K | -771.40K | -681.60K | -670.70K |
| Total Operating Expenses | 112.83M | 120.05M | 133.77M | 121.77M | 121.39M |
| Operating Income | 85.10M | 85.36M | 89.58M | 95.76M | 84.04M |
| Income Before Tax | 77.71M | 73.46M | 90.96M | 98.92M | 88.51M |
| Income Tax Expenses | 28.27M | 26.77M | 36.59M | 39.33M | 37.61M |
| Earnings from Continuing Operations | 49.43 | 46.69 | 54.37 | 59.59 | 50.89 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -72.70K | -75.70K | 45.60K | 345.80K | 1.23M |
| Net Income | 49.36M | 46.61M | 54.42M | 59.94M | 52.13M |
| EBIT | 85.10M | 85.36M | 89.58M | 95.76M | 84.04M |
| EBITDA | 88.51M | 89.16M | 95.00M | 103.46M | 94.51M |
| EPS Basic | 2.63 | 2.62 | 2.71 | 2.77 | 1.78 |
| Normalized Basic EPS | 2.60 | 2.62 | 2.68 | 2.73 | 2.02 |
| EPS Diluted | 2.69 | 2.68 | 2.71 | 2.77 | 1.78 |
| Normalized Diluted EPS | 2.60 | 2.62 | 2.68 | 2.73 | 2.02 |
| Average Basic Shares Outstanding | 309.08M | 299.99M | 291.43M | 290.53M | 290.53M |
| Average Diluted Shares Outstanding | 309.08M | 299.99M | 291.43M | 290.53M | 290.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |